Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 5.52
Ask: 7.00
Change: 0.08 (1.31%)
Spread: 1.48 (26.812%)
Open: 6.20
High: 6.20
Low: 6.20
Prev. Close: 6.12
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Avation sells Airbus jet; Mode Global's bitcoin deal

Thu, 11th Nov 2021 18:36

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Avation PLC - Singapore-based aircraft leasing company - Completes sale of a 20-year-old Airbus A321-200 aircraft for an undisclosed sum. Executive Chair Jeff Chatfield says: "Avation has a policy of focusing on new design, young and fuel-efficient aircraft. This A321 was Avation's oldest aircraft at about 20 years old, and thus was an ideal candidate for disposal".

----------

Mode Global Holdings PLC - London-based payment services app - Teams with payroll provider PayEscape. Partnership will launch a pilot of the UK's first bitcoin payroll product. "Bitcoin payroll is a monthly deduction of net pay that is converted into bitcoin and deposited directly into a user's Mode bitcoin wallet," Mode Global says.

----------

Best of the Best PLC - online competitions provider - Says trading for six months to October 31 in line with guidance given in August. Company says: "Customer acquisition costs have stabilised, albeit at the higher levels previously reported. Engagement from the enlarged player base has also normalised, with average order values and frequency similar to pre-pandemic levels. Trading for the period has, therefore, been consistent with management's revised expectations." In August, Best of the Best warned full-year sales and profit are set to plunge as marketing costs rise and customer demand falls with the easing of lockdown restrictions.

----------

Restore PLC - Redhill, England-based document management and IT recycling business - Says performance in 10 months to October 31 "in line with the board's expectations". Revenue run rate at GBP255 million, topping pre-virus levels by 19%. Annual Ebitda tracking at GBP74 million. "I am delighted with the organic momentum the business is achieving and the major contribution we are seeing from the successful acquisitions we have completed over the past 10 months," Chief Executive Charles Bligh says. Separately, company says it is committed to going net zero by no later than 2035.

----------

Ocean Wilsons Holdings Ltd - Bermudian investment company with subsidiary providing maritime services in Brazil - Says third quarter revenue at Wilson Sons' unit improves 18% year-on-year to USD104.0 million from USD88.1 million. Puts this down to "strong towage volumes and growth in logistics and container terminals over the previous year". Earnings before interest, tax, depreciation and amortisation 18% higher year-on-year at USD44.9 million from USD38.1 million.

----------

SEC Newgate Spa - Milan-based communications, advocacy and research firm - Says results for nine months to September 30 "ahead of management expectations and substantially above the comparable period for the prior year". Says all major businesses had a strong showing.

----------

Regional REIT Ltd - London-based real estate investment trust - Rent roll at end of third quarter expands to GBP75.7 million from GBP61.1 million in June. EPRA occupancy down to 83% from 86% a year earlier. "As expected, EPRA occupancy was impacted by the GBP236.0 million portfolio acquisition made in Q321," company says. Will pay 1.60 pence per share third quarter dividend. Targets 6.5p payout for year, up from 6.4p.

----------

Arbuthnot Banking Group PLC - London-based private and commercial lender - Disposes of remaining 399,538 shares in Secure Trust Bank PLC, raising GBP4.8 million.

----------

Helios Underwriting PLC - London-based investment vehicle, which acquires and consolidates underwriting capacity at Lloyd's - Acquires further limited liability vehicles. Says Queensberry Underwriting Ltd acquired for GBP795,000. Has syndicate capacity of GBP2.2 million.

----------

Gulf Marine Services PLC - Abu Dhabi-based provider of support vessels for offshore oil, gas and renewables industries - Announces two contract extension for a K and S Class vessel. "The extension period on both vessels will commence 1 January 2022, in direct continuance and run for 12 months on the K Class and 24 months for the S Class vessel," Gulf Marine says.

----------

Bezant Resources PLC- copper-gold exploration and development company - Signs joint-venture deal with London-based exploration & resource development company Caerus Mineral Resources PLC. Joint venture covers the Troulli, Kokkinapetra and Anglisides licences held by Caerus in Cyprus. Duo commit initial sum of USD1.0 million towards resource development and taking projects to feasibility status. Caerus manages exploration and resource development phase, while Bezant charged with feasibility studies, mine development and arranging funding. Caerus says: "Once in production, Caerus will, as a priority, be refunded for all direct exploration expenditure committed to getting the projects to the feasibility stage and will receive 20% free-carried interest over the life of mine."

----------

Mkango Resources Ltd - Vancouver-based explorer for rare earth elements - Renews uranium licences in Malawi for five years until October. "With the recent significant increase in international uranium prices, Mkango is currently reviewing strategic exploration and development options, including opportunities for joint ventures and other potential avenues to create further project value," company says.

----------

Oriole Resources PLC - exploration company operating in west Africa - Updates on 25%-owned investee Thani Stratex Resources Ltd. Thani holds 93% interest in Hodine exploration licence in Egypt. After signing binding heads of terms with Red Sea Resources Ltd in March, a licence has been successfully renewed. "Drilling has now commenced on the licence as part of RSR's first option to spend USD1.2 million on exploration within 12 months in return for a 51% interest in Hodine," Oriole says.

----------

Caledonia Mining Corp PLC - gold miner in Zimbabwe - Says revenue in third quarter up 32% annually to USD33.5 million from USD25.4 million. Gross profit improves 26% to USD12.5 million. Adds 18,965 ounces produced during quarter, up from 15,155 ounces a year earlier.

----------

Synairgen PLC - Southampton, England-based drug discovery and biotechnology company - Completes recruitment for Sprinter phase 3 study investigating SNG001 in hospitalised Covid-19 patients.

----------

PureTech Health PLC - Massachusetts, US-based biotechnology company - Says US Food & Drug Administration grants orphan drug designation to PureTech's LYT-200 therapeutic candidate, for treatment of pancreatic cancer. Orphan drug designation is given to treatments which affect fewer than 200,000 US patients.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 Jan 2021 21:16

IN BRIEF: Synairgen Recruits Covid-19 Patients Into Phase II Trial

IN BRIEF: Synairgen Recruits Covid-19 Patients Into Phase II Trial

Read more
13 Jan 2021 10:24

Synairgen Doses First Patient In Covid-19 Treatment Trial

Synairgen Doses First Patient In Covid-19 Treatment Trial

Read more
11 Jan 2021 20:54

COVID SCIENCE-COVID-19 patients still have symptoms 6 months later; interferon may be helpful treatment after all

By Nancy LapidJan 11 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.Half a year later, COVID-19 pat...

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 11:06

Synairgen Gets Fast Track Designation From US FDA For Covid-19 Vaccine

Synairgen Gets Fast Track Designation From US FDA For Covid-19 Vaccine

Read more
18 Dec 2020 10:29

Synairgen makes solid progress with Covid-19 treatment

(Sharecast News) - Respiratory drug development company Synairgen updated the market on its phase 3 trial design evaluating SNG001 as a treatment for patients with Covid-19 on Friday, as well as positive progress on its regulatory path.

Read more
18 Nov 2020 13:59

finnCap Interim Profit More Than Doubles; Chair To Step Down

finnCap Interim Profit More Than Doubles; Chair To Step Down

Read more
13 Nov 2020 14:28

Synairgen surges on positive results for Covid-19 treatment

(Sharecast News) - Synairgen shares surged on Friday after data from trials of its inhaled Covid-19 treatment, SNG001, published in The Lancet Respiratory Medicine, showed positive results in hospitalised patients.

Read more
13 Nov 2020 10:24

Synairgen Drug Helps Recovery In Hospitalised Covid-19 Patients

Synairgen Drug Helps Recovery In Hospitalised Covid-19 Patients

Read more
2 Nov 2020 20:03

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

Read more
15 Oct 2020 11:39

Synairgen Raises GBP80 Million In Placing, To Launch Open Offer

Synairgen Raises GBP80 Million In Placing, To Launch Open Offer

Read more
14 Oct 2020 18:02

IN BRIEF: Synairgen Looks To Raise GBP80 Million For SNG001 Trial

IN BRIEF: Synairgen Looks To Raise GBP80 Million For SNG001 Trial

Read more
29 Sep 2020 12:14

Synairgen Progresses Covid-19 Treatment As Expenses Increase

Synairgen Progresses Covid-19 Treatment As Expenses Increase

Read more
9 Sep 2020 16:04

IN BRIEF: Synairgen Makes Inhaled Interferon Beta Patent Application

IN BRIEF: Synairgen Makes Inhaled Interferon Beta Patent Application

Read more
9 Sep 2020 12:23

Synairgen files for another patent on 'SNG001'

(Sharecast News) - Respiratory drug development company Synairgen updated the market on its intellectual property for the wholly-owned inhaled interferon beta asset 'SNG001' on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.